These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22776965)

  • 1. Early increases in soluble amyloid-β levels coincide with cholinergic degeneration in 3xTg-AD mice.
    Girão da Cruz MT; Jordão J; Dasilva KA; Ayala-Grosso CA; Ypsilanti A; Weng YQ; Laferla FM; McLaurin J; Aubert I
    J Alzheimers Dis; 2012; 32(2):267-72. PubMed ID: 22776965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
    Härtig W; Saul A; Kacza J; Grosche J; Goldhammer S; Michalski D; Wirths O
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):106-20. PubMed ID: 23566195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
    Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
    J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective degeneration of septal and hippocampal GABAergic neurons in a mouse model of amyloidosis and tauopathy.
    Loreth D; Ozmen L; Revel FG; Knoflach F; Wetzel P; Frotscher M; Metzger F; Kretz O
    Neurobiol Dis; 2012 Jul; 47(1):1-12. PubMed ID: 22426397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AβPP accumulation and/or intraneuronal amyloid-β accumulation? The 3xTg-AD mouse model revisited.
    Wirths O; Dins A; Bayer TA
    J Alzheimers Dis; 2012; 28(4):897-904. PubMed ID: 22112547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High tryptophan diet reduces CA1 intraneuronal β-amyloid in the triple transgenic mouse model of Alzheimer's disease.
    Noristani HN; Verkhratsky A; Rodríguez JJ
    Aging Cell; 2012 Oct; 11(5):810-22. PubMed ID: 22702392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic denervation exacerbates amyloid pathology and induces hippocampal atrophy in Tg2576 mice.
    Gil-Bea FJ; Gerenu G; Aisa B; Kirazov LP; Schliebs R; Ramírez MJ
    Neurobiol Dis; 2012 Dec; 48(3):439-46. PubMed ID: 22759926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
    Biochimie; 2018 Mar; 146():105-112. PubMed ID: 29248542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease.
    Shishido H; Kishimoto Y; Kawai N; Toyota Y; Ueno M; Kubota T; Kirino Y; Tamiya T
    Neurosci Lett; 2016 Aug; 629():62-67. PubMed ID: 27373531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer's disease.
    Antequera D; Bolos M; Spuch C; Pascual C; Ferrer I; Fernandez-Bachiller MI; Rodríguez-Franco MI; Carro E
    Neurobiol Dis; 2012 Jun; 46(3):682-91. PubMed ID: 22426395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal GABAergic neurons are susceptible to amyloid-β toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model.
    Krantic S; Isorce N; Mechawar N; Davoli MA; Vignault E; Albuquerque M; Chabot JG; Moyse E; Chauvin JP; Aubert I; McLaurin J; Quirion R
    J Alzheimers Dis; 2012; 29(2):293-308. PubMed ID: 22232004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-beta peptides stimulate the expression of the p75(NTR) neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice.
    Chakravarthy B; Gaudet C; Ménard M; Atkinson T; Brown L; Laferla FM; Armato U; Whitfield J
    J Alzheimers Dis; 2010; 19(3):915-25. PubMed ID: 20157247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology.
    Lopes JP; Blurton-Jones M; Yamasaki TR; Agostinho P; LaFerla FM
    J Alzheimers Dis; 2009; 16(3):541-9. PubMed ID: 19276549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.
    Perez SE; He B; Muhammad N; Oh KJ; Fahnestock M; Ikonomovic MD; Mufson EJ
    Neurobiol Dis; 2011 Feb; 41(2):338-52. PubMed ID: 20937383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models.
    Stargardt A; Gillis J; Kamphuis W; Wiemhoefer A; Kooijman L; Raspe M; Benckhuijsen W; Drijfhout JW; Hol EM; Reits E
    Aging Cell; 2013 Jun; 12(3):499-507. PubMed ID: 23534431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
    J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.